Osaka University team conducts world's first iPS transplant for corneal disease
The team transplanted extremely thin sheet-like corneal tissues produced from another individual’s induced pluripotent stem cells that had been stored at Kyoto University.
Japanese research into growth of human organs in animals gets preliminary approval
A science ministry committee of experts on Wednesday approved Japan's first research involving the injection of human induced pluripotent stem (iPS) cells into fertilized animal eggs with the aim of growing human organs. The project led by Hiromitsu Nakauchi, a professor at the University of ...
Eye-opener: Japanese doctor's work with iPS cells puts macular degeneration on notice
Science has Dr. Masayo Takahashi's mother to thank, in a way, for some of the most notable developments in regenerative medicine using stem cells. More than 35 years ago when Takahashi was contemplating which career she would pursue once she graduated from high school in ...
Patients doing well after landmark 2017 retina transplants via donor iPS cells in Japan
Of the five, four have maintained their level of visual acuity after the operations, while one experienced an improvement in their vision.
Through gene editing, Japan team develops iPS cells with lower rejection risk
A research team in Japan has tapped genome editing to successfully produce induced pluripotent stem cells, known as iPS cells, that have a reduced risk of rejection. The outcome of the research by the team led by Akitsu Hotta, a lecturer at Kyoto University's Center ...
Japan's health ministry approves world's first trials for using iPS cells to treat corneal disease
The study, to be conducted by a team of researchers from Osaka University, will be the sixth time the government has authorized clinical studies using iPS cells.
The green light has been given to a controversial research process that involves implanting human stem cells inside animals and could eventually lead to growing human organs for transplant inside animal hosts. The decision by the Ministry of Education, Culture, Sports, Science and Technology on ...
Japan approves world-first trial using iPS cells to treat spinal cord injuries
The health ministry on Monday approved the world's first clinical test in which artificially derived stem cells will be used to treat patients with spinal cord injuries. A team of researchers from Keio University, which filed a request for the test with the ministry, will ...
Japanese team plans to use iPS cells in clinical trial for cancer patients
A Japanese team is preparing a clinical trial to inject immune cells made from induced pluripotent stem (iPS) cells into patients with head and neck cancer, it has been learned. The team of Riken and Chiba University researchers will file for state approval of the ...
Osaka University approves iPS-linked clinical study for corneal damage
An Osaka University team Wednesday obtained broad approval for its plan to conduct a clinical study on a method to treat patients with a damaged cornea by transplanting cells made from induced pluripotent stem (iPS) cells from other people. The team will now file for ...
Keio researchers plan to treat spinal cord injuries with stem cells
Keio University is poised to conduct the world’s first treatment of patients who have sustained spinal cord injuries using induced pluripotent stem cells, sources said Tuesday.
Kyoto University performs world's first iPS cell transplant for Parkinson's
Researchers hope to develop the treatment into a method that can be covered under Japan’s health insurance system.
